1. Medtech Insight
  2. >>Business
  3. >>Strategy

Zimmer Biomet Cuts 3% Of Its Staff To Save $200m A Year

 
• By Reed Miller

The cuts will cost up to $150m, but the orthopedics company expects to save $200m annually by the end of 2025. The company also announced plans to reduce inventories to prevent excess and obsolescence.

Concept of reorganization or restructuring with businessmans hands facing a group of messy plastic blocks on his desk
• Source: Shutterstock

Zimmer Biomet launched a global restructuring program in late 2023 that will reduce its staff by approximately 3%, the company announced on 8 February.

Zimmer Biomet employs about 18,000 people worldwide, so the cuts will

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 
• By Brian Bossetta

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.

Tariff Pressures Creep Into Dexcom’s Margin Outlook Despite Domestic Manufacturing Shield

 
• By Shubham Singh

Dexcom’s relatively strong position amid tariff-related uncertainty is rooted in its long-standing investments in domestic manufacturing, but raw material inflation is driving cost concerns even in the face of operational efficiencies.

Subsense Develops Nonsurgical, Nanoparticle-Based Brain-Computer Interface For Neurological Disorders

 
• By Marion Webb

Neurotechnology start-up Subsense came out of stealth with $17m in seed funding to develop a nonsurgical, nanoparticle-based brain-computer interface. Medtech Insight spoke with the firm’s new neurotech lead Cyril Eleftheriou about the technology and its potentially wide applications for treating Parkinson’s, epilepsy, inner speech decoding, and more.